Rapid serial naming: Developmental trajectory and relationship with the Bangor Dyslexia Test in Spanish students

This study aimed to analyse the developmental trajectory of the accuracy and speed of naming among dyslexics and developing readers from 1st to 6th grade of primary education. It examined how familiarity with the stimulus influences the performance of different naming tasks in both groups and evaluated the link between naming speed and the Bangor Dyslexia Test. With a descriptive and correlational design, eight naming tasks and the Bangor Dyslexia Test (Miles, 1982; Outón & Suárez, 2010) were administered to a sample of 198 dyslexics and 245 developing readers. The results showed that the dyslexics were slower and more inaccurate in all the naming tasks, compared with the developing readers of the same age. Greater difficulty was observed with the less familiar stimuli. It became evident that naming performance improved with age among both groups of subjects. Finally, a greater number of significant and positive correlations were found between the naming tasks and the Bangor Dyslexia Test in the dyslexic group; the strongest relationship was obtained by naming lettersS

Guías para aplicación de Normas de Calidad para los procesos de Ingeniería de Software en productos desarrollados con Lenguajes de Programación Open Source: relevamiento y aplicación en PYMES de la zona de influencia de la UNER Concordia

El Software Libre u Open Source es una forma de licenciamiento que da a los usuarios la libertad de compartir, estudiar y modificar el software. Este paradigma ha tenido impedimentos para su adopción en ambientes empresariales y comerciales debido a concepciones en muchos casos erróneas. En la actualidad, varias de estas ideas se han desmitificado, brindando una dosis de realidad a las oportunidades y obstáculos de esta filosofía. Esto se manifiesta en una evolución y aceptación paulatina de la adopción de software libre como temática central en la Ingeniería de Software. Este contexto plantea la necesidad de contar con estándares de medición y certificación de calidad específicos para productos de Software Libre y de las competencias y desempeño de empresas y profesionales que utilicen, generen y promocionen el Software Libre. Este proyecto de investigación propuso la formulación de marcos metodológicos y modelos de certificación relacionados con software libre y lenguajes de programación open source, tanto para empresas usuarias como desarrolladoras. De esta manera, se pretendió dar valor agregado y ventaja competitiva a las empresas y profesionales que utilicen, desarrollen y/o promuevan el Software Libre y las tecnologías abiertas

A Comparative Double-Blind Study of Tiaprofenic Acid and Aspirin in the Treatment of Muscular Rheumatism, Fibrositis, Sprains and Soft Tissue Injuries in General Practice

Analgesic and anti-inflammatory properties of tiaprofenic acid 200 mg t.d.s. were compared with those of aspirin 600 mg t.d.s. in 100 patients in general practice suffering from muscular rheumatic pain, fibrositis, sprains and soft tissue injuries. Tiaprofenic acid was shown to be better than aspirin in relieving pain by clinical assessment although both drugs were equally effective according to patients daily assessment. It was not possible to demonstrate any anti-inflammatory action by reduction of swelling, but this was only present in 20% of patients initially. Side-effects, none serious, were similar in both groups. </jats:p

A Controlled Study Comparing a Three Times Daily Dose of Chlordiazepoxide with a Single Night-Time Dose of Trancopal in the Control of Anxiety, Using a Double-Blind, Double-Dummy Technique

A double-blind, double-dummy between-patient study in general practice was carried out to compare the effectiveness of a single, night-time dosage of Trancopal and a three times daily dose of chlordiazepoxide in controlling neurotic anxiety. Ninety-three patients received either 400 mg of Trancopal at night and a chlordiazepoxide placebo capsule three times daily or 10 mg of chlordiazepoxide three times daily and one or two Trancopal placebo tablets at night. Each was treated for four weeks. Three assessments were made using a physicians' rating scale (modified Hamilton Scale). A visual analogue scale was completed by patients initially and at weekly intervals and physicians' and patients' global assessments were made at Weeks 2 and 4. Each treatment group improved considerably over the period of the study both for sleep and anxiety ratings. A statistically significant correlation was found between improvement in day-time fatigue and loss of energy and improvement in sleep disturbance only in the Trancopal group. Loss of concentration was analyzed separately in patients over 40 years old and there was a significant improvement in the physicians' rating in the Trancopal group. There was a very close correlation throughout between the physician's and patient's own assessment of improvement. Few side-effects not already reported at the start of the trial were reported on either treatment. It was concluded that Trancopal at a usual dosage of 400 mg at night offers an effective alternative to a divided dose of chlordiazepoxide. Not only is the beneficial effect on symptoms of anxiety similar but there is some suggestion of a greater improvement in sleep and less interference with day-time functioning. </jats:p

An Open Comparative Trial of Vanquin Tablets and Pripsen Granules in the Treatment of Threadworm Infestation

Thirty-eight patients presenting to their general practitioner with threadworm infestation were admitted to an open, comparative, multicentre trial of Vanquin tablets and Pripsen granules. Efficacy and tolerance were assessed. Twelve of nineteen patients treated with Vanquin had positive results from a peri-anal skin test at the start of treatment, all results were negative after twenty-one days. Fourteen of nineteen patients treated with Pripsen had positive results at the start of treatment and two of these had positive results after twenty-one days. One patient treated with Vanquin and five treated with Pripsen reported side-effects. </jats:p

Analgesic Efficacy and Acceptability of Fenoprofen Combined with Paracetamol and Compared with Dihydrocodeine Tartrate in General Practice

A single-blind between-patient study in general practice was made to examine the acceptability and analgesic efficacy of a combination of fenoprofen (200 mg) and paracetamol (500 mg) given 3 to 4 times daily for a period of 4 to 14 days in the treatment of acute and chronic pain. The combination was compared with dihydrocodeine tartrate (30 mg) in two groups of 75 patients suffering from a wide variety of presenting conditions, including osteoarthritis, spondylitis, lumbago,' sciatica, non-articular rheumatism and trauma. Clinical and patient assessment indicated that the combination was an effective analgesic combination, significantly better in success rate than dihydrocodeine tartrate and with a much lower incidence of side-effects (13% of patients receiving fenoprofen and paracetamol reported side-effects compared to 37% for the dihydrocodeine group). The combination demonstrated particular success in the treatment of non-articular rheumatism. </jats:p